该global dietary supplements market2019年的价值为1756亿美元,预计在预测期内的CAGR增长10.5%。膳食补充剂是提供有效运作人体所需的足够大量营养素的物质。不同类型的膳食补充剂包括蛋白质,维生素,矿物质,纤维,脂肪酸和氨基酸等。膳食补充剂可在市场上提供各种形式,如片剂,胶囊,粉末,饮料和能量栏。一些膳食补充剂有助于维持整体健康和管理健康状况。例如,维生素D和钙提供骨骼强度并降低骨质损失,而叶酸会降低出生缺陷的风险。
肥胖率越来越大,越来越多的疾病主要推动了市场的增长。消费者越来越意识到减肥,卡路里摄入和适当的营养,从而补充了市场的增长。消费者的需求日益增加减肥,并保持健康的同时保持其生活方式已经支持了这个市场的增长。驾驶市场的其他因素包括肥胖的人口,消费者的久坐生活方式,导致生活方式疾病,增加一次性收入,增加政府倡议,以促进健康的生活方式。朝向电子商务的转变,消费者通过在线平台购买膳食补充剂。可用的各种选择与在线平台提供的便于购买者鼓励消费者在线购买膳食补充剂,补充市场的增长。预计未来几年,新兴经济体越来越多的消费者意识的需求将在未来几年提供众多增长机会。
全球膳食补充品市场基于类型,形式,分发信道,最终用户和区域进行分段。基于类型,市场被分段为维生素,矿物质,氨基酸,植物和其他植物。形式的细分分为片剂,胶囊,粉末,软凝胶,液体等。在分销渠道的基础上,市场分段为离线商店和在线平台。在最终用户的基础上,市场被分段为成年人,儿童,婴儿,孕妇和老年人。本报告包括北美,欧洲,APAC和南美洲和MEA市场的详细地域分布。北美进一步分段为美国,加拿大和墨西哥。欧洲分为德国,英国,意大利,法国和欧洲其他地区。亚太地区分叉进入中国,印度,日本和亚太地区的其他地区。亚太地区占2019年全球膳食补充品市场的最大份额。
该leading players in the market are introducing affordable products in the market to cater to the consumers. Global players are entering new markets in developing regions to expand their customer base and strengthen market presence. Herbalife International, a major player in the market offers a wide range of dietary supplements in the market. Its range of dietary supplements includes multivitamin mineral and herbal tablets, personalized protein powder, cell activator tablets, and Cell-U-Loss Advanced among others. Abbott Laboratories is another player in the market, which offers a wide portfolio of nutrition products for adults, infants and new mothers, children, and athletes. In April 2016, EAS, an Abbott company, introduced redesigned Myoplex products to fulfill the nutrition requirements of athletes. The new range of products includes Myoplex Pre-Workout, Myoplex BCAA + Electrolytes, Myoplex Protein Blend, and Myoplex Micellar Casein. Through this launch, the company expanded its offerings in the sports nutrition market. Other leading players in the market include Abott Laboratories, GlaxoSmithKline, Herbalife International, Bayer AG, Pfizer Inc., Nutraceutics Inc., Glanbia Nutritionals, Amway, Carlyle Group, Arkopharma Laboratoires Pharmaceutiques, Bionova Lifesciences, and Danisco A/S among others.